Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110318625 | 11031862 | 5 | F | 200804 | 20160719 | 20150415 | 20160726 | EXP | US-009507513-1107USA01498 | MERCK | 0.00 | M | Y | 0.00000 | 20160726 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110318625 | 11031862 | 1 | PS | PROPECIA | FINASTERIDE | 1 | Oral | 1 MG, QD | U | 20788 | 1 | MG | FILM-COATED TABLET | QD | |||||
| 110318625 | 11031862 | 2 | C | FENOFIBRATE. | FENOFIBRATE | 1 | Oral | UNK MG, UNK | U | U | 0 | ||||||||
| 110318625 | 11031862 | 3 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | U | U | 0 | INHALER |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 110318625 | 11031862 | 1 | Androgenetic alopecia |
| 110318625 | 11031862 | 2 | Product used for unknown indication |
| 110318625 | 11031862 | 3 | Asthma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 110318625 | 11031862 | HO |
| 110318625 | 11031862 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 110318625 | 11031862 | Arteriosclerosis | |
| 110318625 | 11031862 | Blood testosterone decreased | |
| 110318625 | 11031862 | Brain injury | |
| 110318625 | 11031862 | Cholecystectomy | |
| 110318625 | 11031862 | Corticosteroid binding globulin decreased | |
| 110318625 | 11031862 | Depression | |
| 110318625 | 11031862 | Diverticulum | |
| 110318625 | 11031862 | Ejaculation disorder | |
| 110318625 | 11031862 | Endocrine disorder | |
| 110318625 | 11031862 | Erectile dysfunction | |
| 110318625 | 11031862 | Hormone level abnormal | |
| 110318625 | 11031862 | Loss of libido | |
| 110318625 | 11031862 | Male sexual dysfunction | |
| 110318625 | 11031862 | Osteoarthritis | |
| 110318625 | 11031862 | Penile size reduced | |
| 110318625 | 11031862 | Penis injury | |
| 110318625 | 11031862 | Polycythaemia | |
| 110318625 | 11031862 | Primary hypogonadism | |
| 110318625 | 11031862 | Prostatic specific antigen increased | |
| 110318625 | 11031862 | Prostatitis | |
| 110318625 | 11031862 | Prostatomegaly | |
| 110318625 | 11031862 | Renal cyst | |
| 110318625 | 11031862 | Urinary retention |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 110318625 | 11031862 | 1 | 20071221 | 201103 | 0 |